Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The DNA and DNA polymerase-dependent replication machinery, commonly known as the replisome, is a sophisticated multi-protein assembly essential for the accurate duplication of the genome during the S-phase of the cell cycle. This complex includes various DNA polymerases (such as alpha, delta, and epsilon in eukaryotes), helicases, primases, and sliding clamps like PCNA (StatPearls: DNA Replication). Its primary biological role is to synthesize a new DNA strand using a template, ensuring genetic continuity and high-fidelity transmission of information to daughter cells (NCBI: Molecular Biology of the Cell). Beyond replication, components of this machinery are integral to various DNA repair mechanisms, maintaining genomic stability and preventing mutations (PubMed: PMID 30249624). In oncology, this machinery is a major therapeutic target because cancer cells exhibit heightened replication rates to support rapid proliferation (NIH: National Cancer Institute). Additionally, many pathogenic viruses, such as Herpesviridae, encode their own replication machinery, which serves as a specific target for antiviral drugs like Acyclovir (PubChem: CID 135398513). Pharmacological agents typically function as nucleoside analogs that compete with natural dNTPs or act as direct inhibitors of the polymerase enzyme (PubMed: PMID 25614567). While effective, targeting this machinery can lead to significant side effects, such as myelosuppression, due to the inhibition of replication in healthy, rapidly dividing cells (NIH: LiverTox).
Inhibition of DNA synthesis through competitive inhibition of DNA polymerases, incorporation into DNA leading to chain termination, or direct binding to the enzyme-DNA complex to prevent elongation.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DNA and DNA polymerase-dependent replication machinery (DNA replication machinery).